Zhendong Chen

11.4k total citations
75 papers, 881 citations indexed

About

Zhendong Chen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhendong Chen has authored 75 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhendong Chen's work include Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). Zhendong Chen is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). Zhendong Chen collaborates with scholars based in China, United States and Germany. Zhendong Chen's co-authors include Shukui Qin, Jianming Xu, Yoon‐Koo Kang, Shiying Yu, Dafang Zhong, Giuseppe Lentini, Zhongzhen Guan, D. Voliotis, Won Young Tak and Hongming Pan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Zhendong Chen

66 papers receiving 863 citations

Peers

Countries citing papers authored by Zhendong Chen

Since Specialization

Citations

This map shows the geographic impact of Zhendong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhendong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhendong Chen more than expected).

Fields of papers citing papers by Zhendong Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhendong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhendong Chen. The network helps show where Zhendong Chen may publish in the future.

Co-authorship network of co-authors of Zhendong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhendong Chen. A scholar is included among the top collaborators of Zhendong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhendong Chen. Zhendong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trial 2025 ·Cancer Immunology Immunotherapy ·Ying Cheng, Panpan Zhang, Ming Lu, Zhendong Chen, Lijie Song, Si Shi, Feng Ye, Xing Zhang, Baorui Liu, Dongmei Ji, Yanqiao Zhang, Weiguo Su, Michael Shi, (unknown), (unknown), Zhong Chen	0
2	Validating Low‐Dose Iohexol as a Marker for Glomerular Filtration Rate by In Vitro and In Vivo Studies 2025 ·Clinical and Translational Science ·(unknown), Zhendong Chen, (unknown), (unknown), Yohannes Hagos, (unknown), Max Taubert, Dirk Gründemann, Uwe Fuhr	0
3	Preparation of functionalized MXene/carboxylated MWCNTs/SEBS-g-MAH multiscale modified asphalt with superior anti-aging performance 2025 ·Construction and Building Materials ·Wei Chen, Zheming Zhu, (unknown), Ying Su, Yubo Li, Chao Yang, (unknown), Zhendong Chen, (unknown), Xingyang He	0
4	A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer 2024 ·BMC Cancer ·Qingyuan Zhang, Zhonghua Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Simon Li, Hongsheng Li, Changsheng Ye, Tao Sun, Hongjian Yang, Zhendong Chen, Zhihong Wang, Xiaoan Liu, Cuizhi Geng, Xingrui Li, Jin Zhang, Hong Zheng, Zhimin Shao	3
5	Generating 1.2 GHz, 38 fs stretched-pulse directly from a robust mode locked solid-state fiber laser 2024 ·Optics Express ·Ya Wang, (unknown), Zhendong Chen, (unknown), Bin Luo, Zhigang Zhang, Jingbiao Chen	2
6	A Semi-Mechanistic Population Pharmacokinetic Model of Noscapine in Healthy Subjects Considering Hepatic First-Pass Extraction and CYP2C9 Genotypes 2024 ·Drugs in R&D ·Zhendong Chen, Max Taubert, Chunli Chen, (unknown), (unknown), (unknown), (unknown), (unknown), Manfred Wargenau, Bernhard Scheidel, Martin H. J. Wiesen, Elke Schaeffeler, Roman Tremmel, Matthias Schwab, Uwe Fuhr	1
7	A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394 2024 ·Liver Cancer ·Shukui Qin, Weijia Fang, Zhenggang Ren, Shuangyan Ou, Ho Yeong Lim, Feng Zhang, (unknown), Hye Jin Choi, Jiandong Tong, (unknown), (unknown), Ashley Cheng, Chang‐Hsien Lu, (unknown), (unknown), Shital Kamble, Josephine M. Norquist, Wenyan Zhong, Chen Li, Zhendong Chen	7
8	Natural tourmaline activated peracetic acid for efficient degradation of sulfadiazine: Reaction mechanisms and catalyst reusability 2023 ·Progress in Natural Science Materials International ·Zhendong Chen, Liuyang He, Shitai Shen, (unknown), Zhuqi Chen, Li Wu, Lie Yang	5
9	Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Vancomycin in Patients with External Ventricular Drain 2023 ·Antimicrobial Agents and Chemotherapy ·Zhendong Chen, Max Taubert, Chunli Chen, (unknown), Uwe Fuhr, Thomas Weig, Michael Zöller, Suzette Heck, Konstantinos Dimitriadis, Nicole A. Terpolilli, (unknown), Christina Scharf, (unknown), Christoph Dorn, Uwe Liebchen	5
10	Long-term impact of prophylactic central neck dissection in non-invasive classic papillary thyroid carcinoma 2023 ·European Journal of Surgical Oncology ·(unknown), (unknown), (unknown), Zhe Mo, Jie Zhou, Zhendong Chen, Rasa Zarnegar, Thomas J. Fahey, Weibin Wang, Lisong Teng	0
11	Metabolite Identification in the Preclinical and Clinical Phase of Drug Development 2021 ·Current Drug Metabolism ·Yali Wu, Lulu Pan, Zhendong Chen, (unknown), Xingxing Diao, Dafang Zhong	24
12	Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial 2021 ·Cancer Biology and Medicine ·Tianqing Chu, Jun Lü, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, (unknown), Kai Li, Baohui Han	23
13	Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [14C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-Glucuronosyltransferase 2021 ·Drug Metabolism and Disposition ·(unknown), Hua Zhang, Mengling Liu, Guangze Li, Sheng Ma, Zhe Zhang, (unknown), (unknown), Zhendong Chen, Dafang Zhong, Liyan Miao, Xingxing Diao	7
14	Technologies to improve the sensitivity of existing chromatographic methods used for bioanalytical studies 2020 ·Biomedical Chromatography ·Zhendong Chen, (unknown), Dafang Zhong	12
15	Characterization and quantitative determination of henagliflozin metabolites in humans 2020 ·Journal of Pharmaceutical and Biomedical Analysis ·Zhendong Chen, Liang Li, (unknown), Yifan Zhang, Haiyan Liu, Jianjun Zou, Dafang Zhong	8
16	Network Pharmacology‐Based Study on the Mechanism of Gegen Qinlian Decoction against Colorectal Cancer 2020 ·Evidence-based Complementary and Alternative Medicine ·(unknown), Lin Guo, (unknown), Jing Chen, (unknown), Zhendong Chen, Hulun Li	5
17	De novo Assembly and Characterization of the Floral Transcriptomes of Two Varieties of Melastoma malabathricum 2019 ·Frontiers in Genetics ·Tao Zheng, (unknown), (unknown), (unknown), (unknown), Zhendong Chen, (unknown)	6
18	DNA extraction of the 7 species plants of Melastomaceae based on the modified methods of CTAB 2011 ·Guangdong nongye kexue ·Zhendong Chen	2
19	Expression of Ezrin and AKT2 and its clinical significance in human colorectal carcinoma. 2009 ·Chinese Clinical Oncology ·(unknown), Zhendong Chen, (unknown)	1
20	Intravenous flurbiprofen axetil can increase analgesic effect in refractory cancer pain 2009 ·Journal of Experimental & Clinical Cancer Research ·Hongyang Wu, Zhendong Chen, Guoping Sun, Kangsheng Gu, (unknown), (unknown), Yingying Du, Jie Ning	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact